Why DTIL? Precision BioSciences, Inc. Analysis, Price & AI Insights | Whystock
DTIL
$7.69+0.21 (+2.81%)
Market ClosedLast close May 8
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.